# DANDELION Ranks Asthma's Candidate Driver Genes

> A new framework connected human genetic signals to 21 candidate disease-proximal genes, then tested selected mechanisms in cells and mice; it did not discover an asthma treatment.

_Source: Peer-reviewed open-access Cell research article, verified against PubMed, Crossref, OpenAlex, Semantic Scholar and the publisher's supplemental files · 2026-08-19 · 7 min read · Verified against primary sources_

Canonical: https://iyu.app/e/dandelion-asthma-candidate-driver-genes

## The 60-second version

DANDELION integrated trans-regulatory and exome-burden evidence to prioritize 21 candidate disease-proximal genes for asthma.

**Key points**

- The method tries to move from broad association regions to genes closer to disease biology.
- Fifteen of 16 measurable candidates ranked in the top 0.5% in an independent primary CD4 T-cell perturbation dataset.
- CRISPR assays tested epithelial and T-cell phenotypes, with the supplemental T-cell screen showing three donors.
- Loss of SLC27A3 and SCD changed inflammation and airway remodeling in an allergic-asthma mouse model.
- No human treatment, clinical outcome or target-specific safety question was tested.

**Verdict.** A stronger method for prioritizing asthma experiments, not a new therapy or proof that the nominated genes are safe drug targets.

## Full explainer

A Cell study presents **DANDELION**, a framework that connected human genetic signals to **21 candidate disease-proximal genes** for asthma. Cell and mouse experiments strengthen selected links, but the work did not test a drug, enroll patients in a treatment trial, or show improved asthma outcomes.

> **⚑ Caveat:** SLC27A3 and SCD affected inflammation and airway remodeling in an allergic-asthma **mouse model**. That is mechanistic evidence in mice, not evidence that targeting either gene is effective or safe in people.


### The problem — Association signals do not name the driver

Genome-wide association studies can locate variants associated with asthma, but many variants sit outside protein-coding regions and work through regulatory chains. The nearest gene may be only an intermediary. The authors call genes closer to the disease mechanism **disease-proximal genes**, or DPGs.

DANDELION combines two kinds of evidence: trans-regulatory effects measured in disease-relevant tissues, and gene-level burden from rare coding variants in whole-exome sequencing. A mediation-inspired model asks which target genes receive regulatory influence and also carry trait-associated coding burden.

- **GWAS signal:** Locates a region associated with asthma, but may not identify the gene closest to the biological mechanism.
- **Trans-regulation:** Tracks how one gene's regulation is associated with expression changes in distant target genes.
- **Exome burden:** Tests whether rare coding variants grouped within a gene collectively associate with the trait.
- **DANDELION output:** A prioritized candidate list; nomination is not proof of causation or druggability.


### The evidence — The ranking survived several filters

- **21** — asthma DPG candidates
- **15/16** — measurable genes ranked in the top 0.5% in CD4 T-cell data
- **3** — T-cell donors shown in the supplemental screen
- **2** — genes taken into the mouse model

The supplemental analysis lists 21 asthma DPGs. Of those, 16 were expressed in an independent primary CD4 T-cell perturbation dataset; **15 of 16** ranked within that dataset's top 0.5%. The candidates were also enriched in endoplasmic-reticulum and membrane compartments, a biological pattern rather than a clinical endpoint.

CRISPR perturbations then tested airway epithelial barrier phenotypes and T-cell behavior. The supplemental screen identifies samples from three T-cell donors. The abstract reports that most nominated genes changed asthma-related cellular phenotypes, supporting biological relevance without reproducing the full human airway and immune system.


### Animal test — Two genes changed a mouse asthma model

The team disrupted **SLC27A3** and **SCD** in a model of allergic asthma and observed changes in inflammation and airway remodeling. These experiments test whether the genes matter inside a living organism, but the organism was a mouse and the model represents only part of asthma's diversity.

> A candidate can become a better experiment before it becomes a plausible medicine.


### Limits — What the study still cannot establish

- **No human efficacy test:** no patient received a therapy based on these genes.
- **Model boundaries:** cell culture and allergic-asthma mice do not represent every human asthma subtype.
- **Candidate status:** statistical convergence and perturbation support do not establish the safe therapeutic direction for a gene.
- **Data integration:** the study combines multiple genetic and expression resources, so there is no single participant total that describes every analysis.
- **Generalization:** ancestry composition, tissue choice and the ability to measure small trans-effects can influence which genes are ranked.
- **Disclosure access:** PubMed does not display a conflict statement for this record, and the accessible supplement contains figures and result tables; the final article's disclosure section remains the authoritative check.


### Next steps — The map now needs human validation

Independent genetic replication across ancestries and asthma phenotypes, experiments in human airway tissue, and target-specific safety studies are needed before any candidate can move toward treatment development. For now, DANDELION is a way to choose better experiments, **not a reason to change asthma medication or care**.


## Primary sources

- [Telegram post 1421](https://t.me/CNSmydream/1421)
- [Cell paper (DOI 10.1016/j.cell.2026.07.034)](https://doi.org/10.1016/j.cell.2026.07.034)
- [PubMed record (PMID 42580338)](https://pubmed.ncbi.nlm.nih.gov/42580338/)
- [Cell supplemental information](https://ars.els-cdn.com/content/image/1-s2.0-S0092867426008664-mmc1.pdf)
- [Cell supplemental asthma results table](https://ars.els-cdn.com/content/image/1-s2.0-S0092867426008664-mmc5.xlsx)
- [Crossref metadata](https://api.crossref.org/works/10.1016/j.cell.2026.07.034)
- [OpenAlex record (W7202171073)](https://openalex.org/W7202171073)
- [Semantic Scholar record](https://www.semanticscholar.org/paper/b235255011c1c4e0d544b69a2725ba59371f54d4)

---
_Published by iyu (https://iyu.app) — the day's AI news, checked against primary sources and rewritten in plain language. Free to quote with attribution and a link to the canonical URL._